About Lamellar
Lamellar is a company based in Bellshill (United Kingdom) founded in 2007.. Lamellar has raised $18.39 million across 4 funding rounds from investors including Scottish Enterprise, Invesco Perpetual and Invesco. The company has 5 employees as of June 30, 2021. Lamellar operates in a competitive market with competitors including Bausch & Lomb, Kerecis, BONESUPPORT, Sofregen and Arsenal Medical, among others.
- Headquarter Bellshill, United Kingdom
- Employees 5 as on 30 Jun, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lamellar Biomedical Limited
- Date of Incorporation 17 Nov, 2006
- Jurisdiction GLASGOW
-
Annual Revenue
-
Net Profit
$-2.49 M (USD)9as on Jun 30, 2019
-
EBITDA
-
Total Equity Funding
$18.39 M (USD)
in 4 rounds
-
Latest Funding Round
$7.46 M (USD), Series C
May 08, 2017
-
Investors
Scottish Enterprise
& 3 more
-
Employee Count
5
as on Jun 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lamellar
Lamellar has successfully raised a total of $18.39M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $7.46 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $7.5M
-
First Round
First Round
(18 Sep 2007)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2017 | Amount | Series C - Lamellar | Valuation |
investors |
|
| Jul, 2015 | Amount | Series B - Lamellar | Valuation |
investors |
|
| Jan, 2013 | Amount | Series A - Lamellar | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lamellar
Lamellar has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Scottish Enterprise, Invesco Perpetual and Invesco. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage Scottish companies are supported with investment and expertise.
|
Founded Year | Domain | Location | |
|
Diversified asset management services are offered globally by Invesco.
|
Founded Year | Domain | Location | |
|
Business development and leadership training programs are offered to companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lamellar
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lamellar
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lamellar Comparisons
Competitors of Lamellar
Lamellar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bausch & Lomb, Kerecis, BONESUPPORT, Sofregen and Arsenal Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ophthalmic pharmaceuticals and instruments are developed for eye care.
|
|
| domain | founded_year | HQ Location |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| domain | founded_year | HQ Location |
Injectable synthetic bone substitutes are developed for fracture treatment.
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Polymer-based foams and fibers are developed for medical applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lamellar
Frequently Asked Questions about Lamellar
When was Lamellar founded?
Lamellar was founded in 2007.
Where is Lamellar located?
Lamellar is headquartered in Bellshill, United Kingdom. It is registered at Bellshill, Scotland, United Kingdom.
Is Lamellar a funded company?
Lamellar is a funded company, having raised a total of $18.39M across 4 funding rounds to date. The company's 1st funding round was a Series A of $5.3M, raised on Sep 18, 2007.
How many employees does Lamellar have?
As of Jun 30, 2021, the latest employee count at Lamellar is 5.
What does Lamellar do?
Lamellar Biomedical provides its proprietary Lamellasome technology which are mimetics of native extra-alveolar lamellar bodies. They work on developing the Class 3 medical devices, Visco-ease for Radiotherapy-Induced Xerostomia (RIX) and Lamell-eye for moderate to severe Dry Eye Disease (DED). Its lead compound, LMS-611, is also being developed as a novel therapy for Cystic Fibrosis and has EU Orphan Drug status for this indication.
Who are the top competitors of Lamellar?
Lamellar's top competitors include Bausch & Lomb, Kerecis and BONESUPPORT.
Who are Lamellar's investors?
Lamellar has 4 investors. Key investors include Scottish Enterprise, Invesco Perpetual, Invesco, and TRICAPITAL Angels.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.